Dashboard

Viking Therapeutics, Inc.

VKTXNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$4.9B

Price$41.6552w $23.09 – $42.13

Conviction3/ 5

Revenue (TTM)$0

Revenue growth YoY—

P/E (trailing)—

Gross margin—

Operating margin—

Net margin—

52w price change+59.5%

Next earningsOct 28, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

Sep 22
OtherSEC
Viking Therapeutics files 8-K covering items 8.01 and 9.01.
Aug 7
Ownership changeSEC
SEC Form 4 insider transaction filing
Jul 30
Securities offeringSEC
Filed Form S-3ASR automatic shelf registration statement with SEC.
Jul 29
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jul 29
Ownership changeSEC
SEC Form 4 insider transaction filing.
Jul 29
Financial resultsSEC
Viking Therapeutics files 8-K (items 2.02, 9.01) disclosing financial results.
Jul 29
Ownership changeSEC
SEC Form 4 filing reporting insider ownership change.
Jun 3
Ownership changeSEC
SEC Form 4 insider ownership report filed
May 26
OtherSEC
VKTX filed 8-K (items 5.07, 9.01) reporting results of matters submitted to shareholder vote.

Not financial advice — research and opinion only. Disclosures